Emerging evidence points at a significant association and shared genetic traits between adult attention-deficit/hyperactivity disorder (ADHD) and cardiometabolic conditions such as Obesity, Type-2 Diabetes, and cardiovascular disease, which, when inadequately treated, can lead to adverse outcomes and significant costs to society. Various national guidelines on cardiometabolic disease already highlight the importance of concurrent psychiatric disorders, but there is a lack of knowledge around ADHD. This is problematic given that ADHD is a common and serious complex chronic condition among adults.
This is where TIMESPAN steps in, fostering improvements in risk stratification as well as treatments already available for patients with ADHD who also have cardiometabolic disease.
project duration5 years
grant amount5.9 million €
14 countries17 institutions
kick-off1st April 2021